A series of heterodinuclear complexes (M-1-Re) based on a phenanthroline (phen) extended tetramesityl porphyrin ligand (H2-1) has been prepared. The phen moiety of this ligand selectively coordinates a Re(I) tricarbonyl chloride unit, whereas the metal in the porphyrin moiety has been varied: namely, Cu, Pd, Zn, Co, or Fe was used. These dinuclear complexes were fully characterized by standard analytical methods. Additionally, a crystal structure of Cu-1-Re·5.5(C7H8)·0.5(C6H6) could be obtained, and extended time-resolved emission lifetime measurements were conducted. Furthermore, their ability to catalyze the photochemical reduction of CO2 to CO was investigated. Light-driven CO2 reduction experiments were performed in dimethylformamide (DMF) using triethylamine (TEA) as the sacrificial electron donor. The TONs (turnover numbers) of CO were determined and revealed a surprising catalytic activity that is obviously independent from the redox activity of the porphyrin metal. We have recently shown that the parent M-1 compounds are active photocatalysts, but the catalytic activity was dependent on the redox activity of the porphyrin metal. In the case of the new heterodinuclear complexes M-1-Re reported in this study, the catalytic active center seems to be the Re(I) moiety and not the porphyrin. Surprisingly, Zn-1-Re proved to be the most active compound in this series showing a TONCO of 13 after 24 h of illumination using a >375 nm cutoff filter while all other compounds showed minimal activity under this condition.
No takes yet. Share an insight, caveat, or question.
Matlachowski et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: